|
|
|
LifeScienceHistory.com - Check us out on Instagram
Maryland Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MarylandLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Osiris Therapeutics, Inc.
| | | Phone: | (443) 545-1800 | Fax: | (443) 545-1701 | Year Established: | 1992 | Ticker: | OSIR | Exchange: | OTC PINK | Main Contact: | Samson Tom, PhD, MBA, President & CEO | | Other Contacts: | Jason Keefer, CBO Alla Danilkovitch, Ph.D.
Back to Leadership, CSO Joel Rogers, CFO
| | Company Description | Osiris Therapeutics is a world leader in researching, developing, and marketing regenerative medicine products that improve health and lives of patients and lower overall healthcare costs. Having developed the world's first approved stem cell drug, the Company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine — including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in wound care, orthopedics, and sports medicine, including Grafix®, Stravix®, BIO4®, and Cartiform®. Osiris, Grafix, Stravix and Cartiform are registered trademarks of Osiris Therapeutics, Inc., and BIO4 is a registered trademark of Howmedica Osteonics Corp. Osiris makes no claims concerning functional activities of Grafix or Stravix. Although well characterized in scientific literature and studies, preservation of tissue integrity including cells may not be indicative of clinical outcome. | |
|
|
|
|
|